NLG802

N/A

Report date: 2024/09/25 20:00:35
NME

Base Information

Drug NameNLG802
Drug Alias NameNLG-802
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIndoleamine 2,3-dioxygenase inhibitors
TargetsIndoleamine 2,3-dioxygenase
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLankenau Institute For Medical Research
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNewlink Genetics Co
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A